UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Cryo-EM structure of a light chain-derived amyloid fibril from a patient with systemic AL amyloidosis

Nature communications, 2019-03, Vol.10 (1), p.1103-8, Article 1103

2019

Volltextzugriff (PDF)

Cryo-EM reveals structural breaks in a patient-derived amyloid fibril from systemic AL amyloidosis

Nature communications, 2021-02, Vol.12 (1), p.875-875, Article 875

2021

Volltextzugriff (PDF)

Role of mutations and post-translational modifications in systemic AL amyloidosis studied by cryo-EM

Nature communications, 2021-11, Vol.12 (1), p.6434-6434, Article 6434

2021

Volltextzugriff (PDF)

A staging system for renal outcome and early markers of renal response to chemotherapy in AL amyloidosis

Blood, 2014-10, Vol.124 (15), p.2325-2332

2014

Volltextzugriff (PDF)

New Criteria for Response to Treatment in Immunoglobulin Light Chain Amyloidosis Based on Free Light Chain Measurement and Cardiac Biomarkers: Impact on Survival Outcomes

Journal of clinical oncology, 2012-12, Vol.30 (36), p.4541-4549

2012

Volltextzugriff (PDF)

Letermovir prophylaxis is effective in preventing cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation: single-center real-world data

Annals of hematology, 2021-08, Vol.100 (8), p.2087-2093

2021

Volltextzugriff (PDF)

Cryo-EM structure of an ATTRwt amyloid fibril from systemic non-hereditary transthyretin amyloidosis

Nature communications, 2022-10, Vol.13 (1), p.6398-9, Article 6398

2022

Volltextzugriff (PDF)

Longitudinal Left Ventricular Function for Prediction of Survival in Systemic Light-Chain Amyloidosis

Journal of the American College of Cardiology, 2012-09, Vol.60 (12), p.1067-1076

2012

Volltextzugriff (PDF)

Carpal tunnel syndrome and spinal canal stenosis: harbingers of transthyretin amyloid cardiomyopathy?

Clinical research in cardiology, 2019-12, Vol.108 (12), p.1324-1330

2019

Volltextzugriff (PDF)

Clarification on the definition of complete haematologic response in light-chain (AL) amyloidosis

Amyloid, 2021-01, Vol.28 (1), p.1-2

2021

Volltextzugriff (PDF)

Fatal amyloid formation in a patient's antibody light chain is caused by a single point mutation

eLife, 2020-03, Vol.9

2020

Volltextzugriff (PDF)

Polymorphism of Amyloid Fibrils In Vivo

Angewandte Chemie (International ed.), 2016-04, Vol.55 (15), p.4822-4825

International ed. in English, 2016

Volltextzugriff (PDF)

Prognosis and Staging of AL Amyloidosis

Acta haematologica, 2020-01, Vol.143 (4), p.388-400

2020

Volltextzugriff (PDF)

Immunohistochemistry in the classification of systemic forms of amyloidosis: a systematic investigation of 117 patients

Blood, 2012-01, Vol.119 (2), p.488-493

2012

Volltextzugriff (PDF)

In vivo detection of nerve injury in familial amyloid polyneuropathy by magnetic resonance neurography

Brain (London, England : 1878), 2015-03, Vol.138 (Pt 3), p.549-562

2015

Volltextzugriff (PDF)

Common transthyretin-derived amyloid fibril structures in patients with hereditary ATTR amyloidosis

Nature communications, 2023-11, Vol.14 (1), p.7623-7623, Article 7623

2023

Volltextzugriff (PDF)

Light chain mutations contribute to defining the fibril morphology in systemic AL amyloidosis

Nature communications, 2024-06, Vol.15 (1), p.5121-8

2024

Volltextzugriff (PDF)

Reduced-intensity conditioning versus standard conditioning before allogeneic haemopoietic cell transplantation in patients with acute myeloid leukaemia in first complete remission: a prospective, open-label randomised phase 3 trial

The lancet oncology, 2012-10, Vol.13 (10), p.1035-1044

2012

Volltextzugriff (PDF)

Amyloid in biopsies of the gastrointestinal tract—a retrospective observational study on 542 patients

Virchows Archiv : an international journal of pathology, 2016-05, Vol.468 (5), p.569-577

2016

Volltextzugriff (PDF)

Common Fibril Structures Imply Systemically Conserved Protein Misfolding Pathways In Vivo

Angewandte Chemie International Edition, 2017-06, Vol.56 (26), p.7510-7514

2017

Volltextzugriff (PDF)

Daratumumab in first-line treatment of patients with light chain amyloidosis and Mayo stage IIIb improves treatment response and overall survival

Haematologica (Roma), 2024-01, Vol.109 (1), p.220

2024

Volltextzugriff (PDF)

Analysis of the complete lambda light chain germline usage in patients with AL amyloidosis and dominant heart or kidney involvement

PloS one, 2022-02, Vol.17 (2), p.e0264407-e0264407

2022

Volltextzugriff (PDF)

A novel risk score to predict survival in advanced heart failure due to cardiac amyloidosis

Clinical research in cardiology, 2020-06, Vol.109 (6), p.700-713

2020

Volltextzugriff (PDF)

Tandem Autologous/Reduced-Intensity Conditioning Allogeneic Stem-Cell Transplantation Versus Autologous Transplantation in Myeloma: Long-Term Follow-Up

Journal of clinical oncology, 2011-08, Vol.29 (22), p.3016-3022

2011

Volltextzugriff (PDF)

Improved outcomes after heart transplantation for cardiac amyloidosis in the modern era

The Journal of heart and lung transplantation, 2018-05, Vol.37 (5), p.611-618

2018

Volltextzugriff (PDF)

1 – 25 von 357

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(338)
Mit Volltextzugriff
(306)

Publikationsform

Sprache

Englisch
(341)
Japanisch
(41)
Deutsch
(16)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Cryo-EM structure of a light chain-derived amyloid fibril from a patient with systemic AL amyloidosis

Cryo-EM reveals structural breaks in a patient-derived amyloid fibril from systemic AL amyloidosis

Role of mutations and post-translational modifications in systemic AL amyloidosis studied by cryo-EM

A staging system for renal outcome and early markers of renal response to chemotherapy in AL amyloidosis

New Criteria for Response to Treatment in Immunoglobulin Light Chain Amyloidosis Based on Free Light Chain Measurement and Cardiac Biomarkers: Impact on Survival Outcomes

Letermovir prophylaxis is effective in preventing cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation: single-center real-world data

Cryo-EM structure of an ATTRwt amyloid fibril from systemic non-hereditary transthyretin amyloidosis

Longitudinal Left Ventricular Function for Prediction of Survival in Systemic Light-Chain Amyloidosis

Carpal tunnel syndrome and spinal canal stenosis: harbingers of transthyretin amyloid cardiomyopathy?

Clarification on the definition of complete haematologic response in light-chain (AL) amyloidosis

Fatal amyloid formation in a patient's antibody light chain is caused by a single point mutation

Polymorphism of Amyloid Fibrils In Vivo

Prognosis and Staging of AL Amyloidosis

Immunohistochemistry in the classification of systemic forms of amyloidosis: a systematic investigation of 117 patients

In vivo detection of nerve injury in familial amyloid polyneuropathy by magnetic resonance neurography

Common transthyretin-derived amyloid fibril structures in patients with hereditary ATTR amyloidosis

Light chain mutations contribute to defining the fibril morphology in systemic AL amyloidosis

Reduced-intensity conditioning versus standard conditioning before allogeneic haemopoietic cell transplantation in patients with acute myeloid leukaemia in first complete remission: a prospective, open-label randomised phase 3 trial

Amyloid in biopsies of the gastrointestinal tract—a retrospective observational study on 542 patients

Common Fibril Structures Imply Systemically Conserved Protein Misfolding Pathways In Vivo

Daratumumab in first-line treatment of patients with light chain amyloidosis and Mayo stage IIIb improves treatment response and overall survival

Analysis of the complete lambda light chain germline usage in patients with AL amyloidosis and dominant heart or kidney involvement

A novel risk score to predict survival in advanced heart failure due to cardiac amyloidosis

Tandem Autologous/Reduced-Intensity Conditioning Allogeneic Stem-Cell Transplantation Versus Autologous Transplantation in Myeloma: Long-Term Follow-Up

Improved outcomes after heart transplantation for cardiac amyloidosis in the modern era

Suchergebnisse filtern